Our Leadership

Our company is led by a passionate team of professionals with deep experience in the pharmaceutical industry and a proven track record of success in developing and commercializing novel treatments for patients.

Close Button
Photo of JEFFREY M. DAYNO, M.D.
Jeffrey Dayno, MD is Chief Medical Officer of Harmony Biosciences

JEFFREY M. DAYNO, M.D.

Read Bio
Kumar Budur,

Kumar Budur, MD, MS

Read Bio
Mr. Dierks is Chief Commercial Officer for Harmony Biosciences. 

JEFFREY DIERKS, MBA

Read Bio
Mr. Kapadia is Chief Financial Officer and has over 25 years of life sciences industry experience across multiple therapeutic areas and has provided strategic financial oversight and guidance to companies both in the United States and Europe.

SANDIP KAPADIA, CPA, MBA

Read Bio
Mr. Ulrich serves as

CHRISTIAN ULRICH

Read Bio
Cate McCanless is the Head of Corporate Affairs and Public Policy for Harmony Biosciences.

CATE MCCANLESS

Read Bio
Mr. Serafin is the Chief Strategy Officer at Harmony Biosciences and is responsible for leading the company’s corporate strategy, business and corporate development initiatives, and alliance management efforts, including the expansion of the company’s pipeline through the acquisition and licensing of novel rare disease therapies for patients with high, unmet needs.

ANDREW SERAFIN, JD, MBA

Read Bio
Ms. Glover is Chief Compliance Officer at Harmony Biosciences where she is responsible for overseeing the strategic direction and the operational excellence of Harmony’s Corporate Compliance Program.

TRICIA GLOVER

Read Bio
Ms. Murphy is the Head of Human Resources at Harmony Biosciences.

AUDREY MURPHY

Read Bio
Mr. Bradshaw is the Head of Technical Operations at Harmony Biosciences and is responsible for leading the company’s manufacturing, chemistry and controls (CMC) development and quality assurance functions, including manufacturing and supply management strategies for the company’s commercial drug products.

DAVID BRADSHAW

Read Bio
Mr. Knouft is currently responsible for leading and ensuring strategic alignment for all market access and commercial field sales activities. 

DAVID KNOUFT

Read Bio

Board of Directors

Jeff Aronin is chairman and chief executive officer of Paragon Biosciences

Jeff Aronin

Read Bio

Jeffrey M. Dayno, MD
President and Chief Executive Officer
Harmony Biosciences

Antonio Gracias
Managing Partner/
Chief Investment Officer
Valor Equity

Mark Graf
Private Investor
Former Chief Financial Officer
Discover Financial Services

Jack Nielsen
Managing Partner, Vivo Capital LLC

Juan Sabater
Partner
Valor Equity

Gary Sender
Former Chief Financial Officer, Nabriva plc
Independent Board Member & Consultant

Linda Szyper
Former Chief Operating Officer
McCann Health

Dr. Andreas Wicki
CEO
HBM Healthcare Investments (Cayman) Ltd